For research teamsHelp me find a study
Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 4,909-4,920 of 6,115
Drug study icon
TerminatedNCT00771134

Lu AA39959 for depression in bipolarity

This study was terminated in the United States. It is testing Lu AA39959 for depression in bipolarity.

In Atlanta
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
View study
Behavioral study icon
CompletedNCT03641300

Efficacy of Convulsive Therapies for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Vancouver
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionBehavioralOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT01303601

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Shenyang
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 60 Years
Countries
China
Sponsor
China Medical University, China
Condition
Bipolarity, Depression
View study
Drug study icon
WithdrawnNCT01587066

Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life for depression in bipolarity

This study was withdrawn in South Korea. It is testing Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life for depression in bipolarity.

In Naju
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 20 Years to 65 Years
Countries
South Korea
Sponsor
Bo-Hyun Yoon
Condition
Bipolarity, Depression
View study
Device study icon
TerminatedNCT02749006

Efficacy of rTMS in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Calgary
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity, Depression
View study
Drug study icon
TerminatedNCT01093963

Efficacy Study of Lisdexamfetamine to Treat Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Mason
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity, Depression
View study
Behavioral study icon
CompletedNCT05896436

Emotion Focused Therapy for Competitive Athletes

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionBehavioralOver 18 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Anxiety, Depression
View study
Drug study icon
TerminatedNCT00464191

Escitalopram for depression in bipolarity

This study was terminated in Norway. It is testing escitalopram for depression in bipolarity.

In Nordfjordeid
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
Norway
Sponsor
Nordfjord Psychiatric Centre
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT01256177

Quetiapine Fumarate Extended Release for depression in bipolarity

This study is completed in China. It is testing quetiapine Fumarate Extended Release for depression in bipolarity.

Multiple locations, including Baoding
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
AstraZeneca
Condition
Bipolarity, Depression
View study
Other study type icon
CompletedNCT06393322

Evaluate the Usefulness of Mental Health e-Learning

This summary needs review. Please check the official study record and contact the research team for details.

In Hamilton
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOtherOver 45 Years
Countries
Canada
Sponsor
McMaster University
Condition
Anxiety, Depression
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.